These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
590 related articles for article (PubMed ID: 23260550)
1. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. Hsieh TC; Pastuszak AW; Hwang K; Lipshultz LI J Urol; 2013 Feb; 189(2):647-50. PubMed ID: 23260550 [TBL] [Abstract][Full Text] [Related]
2. Influence of testosterone gel treatment on spermatogenesis in men with hypogonadism. George M; Yulia T; Svetlana K Gynecol Endocrinol; 2014 Oct; 30 Suppl 1():22-4. PubMed ID: 25200823 [TBL] [Abstract][Full Text] [Related]
3. The Use of HCG-Based Combination Therapy for Recovery of Spermatogenesis after Testosterone Use. Wenker EP; Dupree JM; Langille GM; Kovac J; Ramasamy R; Lamb D; Mills JN; Lipshultz LI J Sex Med; 2015 Jun; 12(6):1334-7. PubMed ID: 25904023 [TBL] [Abstract][Full Text] [Related]
4. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men. Zhang GY; Gu YQ; Wang XH; Cui YG; Bremner WJ J Androl; 1998; 19(6):761-8. PubMed ID: 9876028 [TBL] [Abstract][Full Text] [Related]
5. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. Finkel DM; Phillips JL; Snyder PJ N Engl J Med; 1985 Sep; 313(11):651-5. PubMed ID: 3927163 [TBL] [Abstract][Full Text] [Related]
6. Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man. Matsumoto AM; Karpas AE; Bremner WJ J Clin Endocrinol Metab; 1986 Jun; 62(6):1184-92. PubMed ID: 3084535 [TBL] [Abstract][Full Text] [Related]
7. [The treatment of hypogonadism and maintenance of fertility in men]. Rabijewski M Pol Merkur Lekarski; 2016 Mar; 40(237):198-201. PubMed ID: 27088205 [TBL] [Abstract][Full Text] [Related]
8. Age and duration of testosterone therapy predict time to return of sperm count after human chorionic gonadotropin therapy. Kohn TP; Louis MR; Pickett SM; Lindgren MC; Kohn JR; Pastuszak AW; Lipshultz LI Fertil Steril; 2017 Feb; 107(2):351-357.e1. PubMed ID: 27855957 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men. Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800 [TBL] [Abstract][Full Text] [Related]
10. Hormonal replacement therapy with HCG and HU-FSH in thalassaemic patients affected by hypogonadotropic hypogonadism. Cisternino M; Manzoni SM; Coslovich E; Autelli M J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():885-90. PubMed ID: 10091162 [TBL] [Abstract][Full Text] [Related]
11. Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone. Bouloux PM; Nieschlag E; Burger HG; Skakkebaek NE; Wu FC; Handelsman DJ; Baker GH; Ochsenkuehn R; Syska A; McLachlan RI; Giwercman A; Conway AJ; Turner L; van Kuijk JH; Voortman G J Androl; 2003; 24(4):604-11. PubMed ID: 12826700 [TBL] [Abstract][Full Text] [Related]
12. Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism. Sinisi AA; Esposito D; Maione L; Quinto MC; Visconti D; De Bellis A; Bellastella A; Conzo G; Bellastella G Hum Reprod; 2008 May; 23(5):1029-34. PubMed ID: 18343809 [TBL] [Abstract][Full Text] [Related]
13. Testosterone Replacement Therapy Versus Clomiphene Citrate in the Young Hypogonadal Male. Scovell JM; Khera M Eur Urol Focus; 2018 Apr; 4(3):321-323. PubMed ID: 30131284 [TBL] [Abstract][Full Text] [Related]
14. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. Warne DW; Decosterd G; Okada H; Yano Y; Koide N; Howles CM Fertil Steril; 2009 Aug; 92(2):594-604. PubMed ID: 18930225 [TBL] [Abstract][Full Text] [Related]
15. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory. Khera M; Bhattacharya RK; Blick G; Kushner H; Nguyen D; Miner MM J Urol; 2011 Sep; 186(3):1005-11. PubMed ID: 21788049 [TBL] [Abstract][Full Text] [Related]
16. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy. Lanfranco F; Zitzmann M; Simoni M; Nieschlag E Clin Endocrinol (Oxf); 2004 Apr; 60(4):500-7. PubMed ID: 15049966 [TBL] [Abstract][Full Text] [Related]
17. Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study. Chen YW; Niu YH; Xu H; Wang DQ; Jiang HY; Pokhrel G; Wang T; Wang SG; Liu JH Asian J Androl; 2019; 21(4):413-418. PubMed ID: 30604694 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of clomiphene citrate treatment in young hypogonadal men. Katz DJ; Nabulsi O; Tal R; Mulhall JP BJU Int; 2012 Aug; 110(4):573-8. PubMed ID: 22044663 [TBL] [Abstract][Full Text] [Related]
19. The effect of human chorionic gonadotropin-based hormonal therapy on intratesticular testosterone levels and spermatogonial DNA synthesis in men with non-obstructive azoospermia. Shinjo E; Shiraishi K; Matsuyama H Andrology; 2013 Nov; 1(6):929-35. PubMed ID: 24123916 [TBL] [Abstract][Full Text] [Related]
20. Hormonal therapy of male hypogonadism. Matsumoto AM Endocrinol Metab Clin North Am; 1994 Dec; 23(4):857-75. PubMed ID: 7705324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]